RepliCel Life Sciences Inc (OTCQB:REPCF)

0.34
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
0.26
Today|||52-Week Range
0.64
+4.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-3.8M-3.4M-27.7K-4.7M
 
 
 
 
 
Depreciation7.7K6.1K5.9K6.9K
 
 
 
 
 
Total Other Cash Flow977.1K265.2K519.5K717.2K
 
 
 
 
 
Funds From Operations-2.8M-3.1M497.7K-4.0M
 
 
 
 
 
Funds From/For Other Operating Expenses380.6K-134.3K17.7K42.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-3.1M-3.0M480.0K-4.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-1.4M
 
 
Capital Expenditures-13.1K-9.1K-7.6K-9.2K
 
 
 
 
 
Net Cash Flow Investing-13.1K-9.1K-7.6K-1.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale2.5M2.8M1.1M4.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.0035.7K45.3K0.00
 
 
 
Net Cash Flow - Financing2.5M2.8M1.1M4.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash------0.00--
 
Net Change In Cash-653.3K-180.9K1.5M-1.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account